GH Research PLC (GHRS) Peer Comparison

$27.89

$-0.76 (-2.65%)

As on 28-Aug-2026 13:40EDT

Market cap

$2,046 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

5.5

Div. Yield

0 %

Edit

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Market cap ($ Mln)	2,046	8,108	485
Revenue ($ Mln)	--	1,668	55
Net Profit ($ Mln)	-62.27	66.12	-43.99
Net Margin (%)	--	3.97	-80.67
RoE (%)	-19.48	3.65	-15.51
Price to Earnings	--	127.18	--
Price-To-Book	5.48	4.48	1.69

Cashflow
Ratios

Cashflow ($ Mln)

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Cash From Operating Activities	-43.55	520.75	-163.58
Cash Flow from Investing Activities	46.17	295.50	-0.14
Cash from Financing Activities	139.65	12.38	-0.14
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
ROCE (%)	-20.99	14.09	-61.63
ROE (%)	-19.48	3.65	-15.51
ROA (%)	-17.58	1.52	-11.26
EBIT Margin (%)	--	9.38	-79.97
Net Margin (%)	--	3.97	-80.67
Cash Profit Margin (%)	--	0.00	0.00

Growth Ratios

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Revenue Growth (%)	--	10.79	427.32
EBIT Growth (%)	-57.95	-62.86	81.26
Net Profit Growth (%)	-51.82	-81.02	85.48
EPS Growth (%)	-33.77	-81.45	85.23
Book Value Growth (%)	10.54	12.49	-8.69

Valuation Ratios

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Price / Earnings	-16.32	19.54	-2.11
Price / Book Value	2.82	2.60	1.83
Dividend Yield (%)	--	--	--
EV/EBITDA	-10.69	10.49	-1.12
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Debt to Equity	0.00	0.00	0.00
Short term debt to equity ratio	0.00	0.02	0.01
Current Ratio	28.70	2.30	25.05
Quick Ratio	28.70	1.85	25.05
Interest Coverage	-308.80	2.65	--

Operating Efficiency Ratios

	GH Research PLC (GHRS)	Alkermes (ALKS)	Prothena (PRTA)
Debtors to sales (%)	--	27.37	0.00
Asset Turnover	0.00	0.38	0.14
Receivable days	--	89.53	0.00
Inventory Days	--	352.79	--
Payable days	4,096.25	142.77	673.13
Cash Conversion Cycle	--	299.55	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly